Abstract The ubiquitously expressed amyloid precursorlike protein 2 (APLP2) has been previously found to regulate cell surface expression of the major histocompatibility complex (MHC) class I molecule K d and bind strongly to K d . In the study reported here, we demonstrated that APLP2 binds, in varied degrees, to several other mouse MHC class I allotypes and that the ability of APLP2 to affect cell surface expression of an MHC class I molecule is
Introduction
Major histocompatibility complex (MHC) class I molecules trigger the lysis of cells bearing viral or tumor-specific antigens by presenting peptide fragments of the antigens at the cell surface to T lymphocytes. The peptides first associate with beta 2-microglobulin (β 2 m)-associated MHC class I heavy chains in the endoplasmic reticulum (ER), with the assistance of several proteins in an intricately regulated process (Cresswell et al. 1999; Serwold et al. 2002; Saric et al. 2002; Paquet et al. 2004; Park et al. 2006) . Beyond the ER, there is additional regulation of MHC class I molecule cell surface expression (Paquet et al. 2004; Joyce 1997; Marguet et al. 1999; Spiliotis et al. 2000; Sohn et al. 2001; Pencheva and Edidin 2001; Paulsson et al. 2002) . A protein that has been shown to bind to MHC class I molecules beyond the ER is amyloid precursor-like protein 2 (APLP2) (Feuerbach and Burgert 1993; Sester et al. 2000; Morris et al. 2003) . In addition to its effects on MHC class I molecules, involvement in several other cellular processes (e.g., mitosis, nerve growth, and cell migration) has been reported for APLP2 (Thinakaran et al. 1995; Rassoulzadegan et al. 1998; Guo et al. 1998; Cappai et al. 1999; Li et al. 1999) . Structurally, APLP2 is a ubiquitously expressed transmembrane protein bearing an ectodomain that can be proteolytically clipped off and then secreted (Slunt et al. 1994) .
APLP2 has been shown to down-regulate the surface expression of the MHC class I molecule K d (Morris et al. 2003) . For APLP2 to associate with K d , β 2 m expression is required (Sester et al. 2000) . Evidence indicates that APLP2 interacts with the region of the MHC class I molecule that includes the peptide-binding groove. For example, supplementing cell lysates with K d peptide ligands results in the release of APLP2 from K d (Feuerbach and Burgert 1993) . In addition, APLP2 has been shown to associate preferentially with the folded conformation of the MHC class I molecule K d (Morris et al. 2003) , which suggests that APLP2 binds to the K d N-terminal domains. Here, we report our findings that APLP2 binds to H2 class I molecules in addition to K d , with the strength of interaction dependent on the particular MHC allotype. Our results show that APLP2 affects the cell surface expression of L d , but to a lesser extent than K d . In addition, we demonstrated that APLP2 interacts with K d in vesicular compartments and in the Golgi, but L d only associates with APLP2 in the Golgi. We also discovered that multiple domains of the MHC class I heavy chain influence MHC binding to APLP2 and that the transfection of human β 2 m into mouse cells alters the avidity of MHC/APLP2 interaction. Thus, both polymorphic and conserved portions of MHC class I molecules influence APLP2's binding and regulation of MHC class I cell surface expression.
Materials and methods

Antibodies
The 34-1-2 monoclonal antibody binds to the α1 and/or α2
, and D q (Ozato et al. 1983 ). The 34-1-2 antibody also weakly recognizes D b and L d , but can bind more strongly to L d heavy chains that are associated with human β 2 m, as well as to certain L d mutants with substitutions located in the peptide-binding groove (Ozato et al. 1983; Nieto et al 1989; Solheim et al. 1995) . The SF1.1.1 monoclonal antibody binds to the α3 domain of K d (Cox et al. 1991) . The 64-3-7 monoclonal antibody recognizes L d that has an open, peptide-free groove (Cox et al. 1991; Smith et al. 1993; Smith et al. 1995) , and 64-3-7 can also bind to open forms of other MHC class I heavy chains into which the 64-3-7 epitope has been inserted (Yu et al. 1999; Myers et al. 2000; Harris et al. 2001; Lybarger et al. 2001) . The addition of the 64-3-7 epitope into K d and other MHC class I molecules has been shown not to interfere with peptide ligand binding or expression at the cell surface (Yu et al. 1999; Myers et al. 2000; Harris et al. 2001; Lybarger et al. 2001) . The 30-5-7 antibody binds to the α2 domain of folded L d Smith et al. 1995; Ozato et al. 1980; Evans et al. 1982; Solheim et al. 1993) (Evans et al. 1982; Solheim et al. 1993; Ozato and Sachs 1981) . BBM1.1 recognizes human β 2 m (Brodsky et al. 1979) . All the anti-H2 antibodies used in this study, as well as the BBM1.1 antibody, were gifts from Dr. T. Hansen (Washington University, St. Louis, MO, USA). The antibody recognizing APLP2 that was used in these studies was prepared by rabbit immunization with full-length mouse APLP2; this antibody was purchased from Calbiochem. The PanAb5 antibody against β-actin was purchased from Novus Biologicals.
Cell lines
For these studies, the cell lines were cultured in RPMI 1640 medium (Invitrogen) that was supplemented with 15% fetal bovine serum, pyruvate, glutamine, and (Cox et al. 1991; Lee et al. 1988 ). The HeLa cell line was a gift from Dr. W. Maury (University of Iowa, Iowa City, IA, USA). HeLa cells were transfected with a cDNA for K d or for a K d heavy chain bearing the 64-3-7 epitope (Yu et al. 1999) (Solheim et al. 1993 ). The 721.221 cell line is a B lymphoblastoid cell line that does not express HLA-A, HLA-B, or HLA-C (Shimizu et al. 1988; Shimizu and DeMars 1989) 
Immunoprecipitations and Western blots
In these studies, immunoprecipitations and Western blotting were performed by protocols similar to published methods (Turnquist and Solheim, 2001) . Before immunoprecipitations, cells were washed in 20 mM iodoacetamide in phosphate-buffered saline (PBS) (Sigma-Aldrich, St. Louis, MO, USA) three times and then lysed in 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) lysis buffer. The lysis buffer was composed of 1% CHAPS (Roche Applied Science, Indianapolis, IN, USA) in Trisbuffered saline (pH 7.4) with freshly added 0.2 mM PMSF, 20 mM iodoacetamide, and excess antibody. After a 1-h incubation on ice, the lysates were centrifuged to pellet the cell nuclei, and the lysate supernatants were added to Protein A-Sepharose beads (Amersham Biosciences, Piscataway, NJ, USA) and mixed intermittently for 45 min. The beads were then washed four times in 0.1% CHAPS/ 20 mM iodoacetamide in TBS (pH 7.4) and boiled for 5 min in 0.125 M Tris (pH 6.8)/2% SDS/12% glycerol/ 0.02% bromphenol blue to elute the proteins from the beads.
Prior to some of the immunoprecipitations of mouse MHC class I molecules from transfected L cells, the cells were grown in methionine-and cysteine-free medium for 30 min and then radiolabeled with [
35 S]-methionine/ cysteine for 30 min. The additional steps in the immunoprecipitation procedure were performed as described above. Following electrophoresis, the radiolabeled proteins were transferred to Immobilon-P membranes (Millipore), which were subsequently dried and autoradiographed to visualize the immunoprecipitated MHC class I heavy chain bands.
For Western blotting, after elution the immunoprecipitates were electrophoresed on precast SDS-PAGE gels (Invitrogen) and then the proteins were transferred to Immobilon-P membranes (Millipore). Following overnight blocking in 10% (w/v) dry milk dissolved in 0.05% Tween 20 in PBS, the blotting membranes were incubated in primary antibody diluted in milk for 2 h, washed with 0.05% Tween 20/PBS three times, and incubated for 1 h in biotin-conjugated goat anti-mouse or anti-rabbit IgG (Caltag Laboratories) diluted in 0.05% Tween 20/PBS. After three 0.05% Tween 20/PBS washes, the membranes were incubated with streptavidin-conjugated horseradish peroxidase (Zymed) diluted in 0.05% Tween 20/PBS for 1 h. The membranes were then washed three times with 0.3% Tween 20/PBS, and treated with enhanced chemiluminescence Western blot developing reagents (Amersham Biosciences). The blots were exposed to Kodak BioMax film (Eastman Kodak Co.) to allow visualization of the bands. For some experiments, protein bands were quantified by multiplying the mean of the luminosity by the pixel number as determined by the histogram function of Adobe Photoshop, as previously described (Ng et al. 2003; Eck et al. 2006 ).
Immunofluorescence analysis
To assess the co-localization of K d and APLP2 at steady state, HeLa-etK d or HeLa-L d cells were grown on glass cover slips, transiently transfected for 24 h with APLP2-FLAG using Effectene reagent, and fixed with 4% (vol/vol) paraformaldehyde in PBS for 10 min. Fixed cells were incubated with primary antibodies (34-1-2 for K d or 30-5-7 for L d ) and rabbit anti-FLAG antibody prepared in staining solution [0.2% saponin (wt/vol) and 0.5% (wt/vol) bovine serum albumin in PBS] for 1 h at room temperature. After three washes in PBS (5 min/wash), the cells were incubated with the appropriate fluorochrome-conjugated secondary antibody mixture (Alexa Fluor goat anti-mouse 568-nm and Alexa Fluor donkey anti-rabbit 488-nm antibodies) in staining solution for 30 min at room temperature. After three more washes in PBS (5 min/wash), the cells were mounted and analyzed with a Zeiss LSM 5 Pascal confocal microscope, using a ×63 lens with 1.4 numerical aperture. The degree of co-localization of APLP2 with either K d or L d was quantified with the Image J software, utilizing the JACoP program (http://rsb.info.nih.gov/ij/plugins/track/ jacp.html) for the calculation of Pearson's coefficients. Ten sets of images (acquired using the same optical settings) were used for each pairwise comparison, and the Pearson coefficients and standard errors of the mean were calculated.
To determine whether a large, compact intracellular compartment in which APLP2 and K d were co-localized was the Golgi, the approach was to transfect transiently etK d , APLP2-FLAG, and YFP-Golgi (Clontech) into HeLa cells using Effectene (Qiagen), fix the HeLa cells with 4% (vol/vol) paraformaldehyde in PBS for 10 min, and then incubate the fixed cells with anti-K d antibody 34-1-2 and rabbit anti-FLAG in staining solution for 1 h at room temperature. After three PBS washes of 5 min each, the cells were incubated with secondary antibodies (Alexa Fluor goat anti-mouse 430 nm and Alexa Fluor goat anti-rabbit 568-nm antibodies) in staining solution for 30 min at room temperature, washed three times in PBS, and mounted for image analysis with a Zeiss LSM 5 Pascal confocal microscope, using a ×63 lens with 1.4 numerical aperture.
Flow cytometry assays
In flow cytometry assays, cells were suspended at 5×10 6 / ml in PBS with 0.2% BSA and 0.1% sodium azide. Cell suspension aliquots in volumes of 0.1 ml were distributed to wells in a 96-well plate. The cells were incubated with excess monoclonal antibody or with BSA/azide/PBS alone (as a control) at 4°C for 30 min, washed twice, and incubated with a PE-conjugated, Fc-specific F(ab′) 2 portion of goat anti-mouse IgG (Jackson ImmunoResearch) at 4°C for 30 min. The cells were washed three times, resuspended in BSA/azide/PBS, and analyzed with the use of a FACSCalibur flow cytometer and Cell Quest software (BD Biosciences).
Results
The polymorphism of H2 class I molecules influences their association with APLP2 Our laboratory and others have shown that APLP2 binds to K d (Sester et al. 2000; Morris et al. 2003) . In this study, we investigated the association of APLP2 with a diverse set of mouse MHC class I molecules individually expressed in the mouse L fibroblast cell line. As shown in Fig. 1a (Fig. 1b) .221, and L cell lysates were electrophoresed on a 4-20% gel, transferred to a blotting membrane, and probed with anti-APLP2 antiserum. Bands were quantified by multiplying the luminosity mean by the pixel number (as determined by Adobe Photoshop), and the ratio of the L cell APLP2 band to the HeLa APLP2 band was calculated to be 1.3 compared (by Western blotting for APLP2), there was no indication that HeLa expresses more APLP2 (Fig. 1c). (Interestingly, the intracellular expression of APLP2 in the human HLA-A, HLA-B, and HLA-C class I-deficient cell line 721.221 was much lower than in L cells or HeLa cells (Fig. 1c) (Fig. 2b) . At the highest level of transfected human β 2 m, D d folding was also facilitated, as shown by the increased amount of immunoprecipitated folded D d heavy chain (Fig. 2b) . At a medium level of human β 2 m transfection, however, there was little or no change in the level of folded D d , but there was still evidence of increased APLP2 association (Fig. 2b) . Human β 2 m transfection also slightly increased APLP2 association with L q and D b , but had virtually no effect on APLP2 association with D q in L cell transfectants (Fig. 2c and data not shown) . Thus, transfection of human β 2 m was able to increase APLP2 interaction with several mouse MHC class I allotypes in mouse cells.
Potentially, direct association between APLP2 and β 2 m could be occurring and this interaction could be stronger for human β 2 m than mouse β 2 m. To investigate whether there was evidence of direct binding of APLP2 to human β 2 m, we performed human β 2 m immunoprecipitations on L+hβ 2 m cells and L cells, and probed the immunoprecipitates for associated APLP2. Immunoprecipitation of human β 2 m from L+hβ 2 m lysates did co-immunoprecipitate some proteins of the appropriate molecular weight to be the endogenous K k and D k molecules (Fig. 2c, top panel) , but little or no APLP2 was co-immunoprecipitated (Fig. 2c,  bottom panel) . Thus, the effect of human β 2 m on APLP2 , and β 2 m itself does not strongly associate with APLP2. The indicated immunoprecipitations from radiolabeled cell lysates were performed, and samples of the immunoprecipitates were electrophoresed on a 4-20% gel. The separated proteins were transferred to blotting membranes that were subsequently dried and autoradiographed to visualize the immunoprecipitated HC (top panel). The immunoprecipitates were also electrophoresed on 4-20% gels for protein transfer to blotting membranes that were probed with antiserum against APLP2 (bottom panel) association with mouse MHC class I molecules was likely not due to direct interaction between β 2 m and APLP2, but rather to the indirect effects of human β 2 m on the MHC class I heavy chain conformation. In addition, these data suggest that K k and D k (the endogenous H2 class I molecules in L cells) are not strongly associated with APLP2 in L cells, again indicating that there is allotypic specificity in MHC class I binding to APLP2.
MHC polymorphism influenced APLP2 co-localization with H2 class I molecules In addition to comparing the co-immunoprecipitation of APLP2 with K d and L d expressed in HeLa cells (Fig. 1b) (Fig. 3) . We have identified this large compartment containing associated APLP2 and K d as the Golgi (Fig. 4) . K d and APLP2 were also associated in intracellular vesicles, but the interaction between L d and APLP2 was limited to the large compartment and was not observed within the vesicles (Fig. 3) .
We also quantified co-localization of APLP2 blotting confirmed down-regulation of APLP2 but not β-actin by the APLP2 siRNA (Fig. 5a ). Our flow cytometric results with K d were similar to those we previously obtained with transient APLP2 siRNA expression ( Fig. 5b; Morris et (Fig. 6b) . (Fig. 6c) .
Discussion
In this study, we demonstrated that APLP2 interacts with certain other murine MHC class I molecules in addition to K d (Fig. 1) (Fig. 1a and b ). APLP2 could be seen co-localized with both K d and L d in a large, compact cellular compartment (identified as the Golgi), but APLP2 co-localization with L d in vesicular cellular compartments was not observed (Figs. 3 and 4) . These data imply that the strong binding between APLP2 and K d might be necessary to maintain the interaction during transport into these vesicles.
The fact that the binding of APLP2 to MHC class I molecules was found to be influenced by MHC class I heavy chain polymorphism (Fig. 1a and b) (Fig. 6) . Thus, APLP2 presumably binds to more than one site on the MHC class I heavy chain. Evidence that binding is influenced by MHC class I polymorphism (directly or indirectly) has also been shown for tapasin (Peh et al. 2000; Turnquist et al. 2000; Turnquist et al. 2002a; Hildebrand et al. 2002; Park et al. 2003; Zernich et al. 2004; Thammavongsa et al. 2006) . Furthermore, like APLP2, tapasin interacts with more than one domain on the MHC class I heavy chain; there are data supporting tapasin interaction with both the α2 and α3 domains of the MHC class I molecule (Turnquist et al. 2002b) .
The expression of human β 2 m in L cells increased the association of H2 class I molecules with APLP2 (Fig. 2) . A previous study found that the co-precipitation of a 105-kDa protein with D b was facilitated by the presence of excess human β 2 m (Townsend et al. 1990 ). As first theorized by others (Feuerbach and Burgert 1993; Sester et al. 2000) , this large protein co-precipitating with D b could be APLP2; our findings are supportive of this notion. The results shown in Fig. 2c suggest that human β 2 m does not interact directly and strongly with APLP2. Instead, human β 2 m may increase APLP2 binding to mouse MHC class I heavy chains indirectly by influencing the conformation of the MHC class I heavy chain α1/α2 region. The conformation of mouse ) has been shown to be stabilized better by human β 2 m than mouse β 2 m (Shields et al. 1998; Shields et al. 1999) . For K d , the stabilizing effect of human β 2 m has been tracked to aspartate 53; mutation of this position decreases the stabilization approximately to the level of mouse β 2 m (Shields et al. 1998) . The aspartate at position 53 also influences D d stabilization by human β 2 m, and other positions in human β 2 m play a role in D d stabilization as well (Shields et al. 1998; Shields et al. 1999) . Several studies have shown that xenogeneic β 2 m can alter the conformation of the outer domains of the MHC class I molecule and affect T cell recognition (Nieto et al. 1989; Shields et al. 1998; Rocca et al. 1992; Kahn-Perles et al. 1987; Achour et al. 2006; Benoit and Tan 2007) . Thus, it is most likely that human β 2 m alters mouse MHC class I heavy chain conformation in some way that strengthens APLP2 binding to the MHC heavy chain. As a distant possibility, it should also be kept in mind that our results do not exclude that some mouse MHC class I heavy chains (e.g., K d ) could, by binding to human β 2 m, cause human β 2 m to adopt a conformation that allows it to bind well to APLP2 directly.
APLP2 was expressed at similar levels in the mouse L cells and human HeLa cells, but the APLP2 level in 721.221 cells was much lower than in either L or HeLa cells (Fig. 1c) . Since 721.221 cells lack expression of HLA-A, HLA-B, and HLA-C, this observation raises the question of whether MHC class I heavy chains normally increase the expression of APLP2. To address this point, the level of APLP2 in MHC class I-transfected 721.221 cells could be compared to the level in untransfected 721.221 cells.
Following transfection with APLP2 siRNA, the expression of L d , like K d , was increased at the cell surface, with L d expression increased to a lesser extent than K d (Fig. 5 ). These surface expression results parallel the weaker binding of L d to APLP2, relative to K d binding to APLP2 (Fig. 1a  and b (Fig. 6c) , even though the intracellular expression of K d /L d was lower than the intracellular expression of K d (Fig. 6b) . Furthermore, K d /L d , unlike K d , was weakly associated with APLP2 (Fig. 6b) . The results shown in Figs. 5 and 6 extend our previous finding that APLP2 has a down-regulatory effect on K d surface expression (Morris et al. 2003) by showing that partial reduction of the strength of MHC/APLP2 binding (as seen for L d and K d /L d , relative to K d ) is paralleled by a lessening of the effect of APLP2 on the surface expression of the MHC molecule. These findings further support a model in which the binding of APLP2 to the MHC class I molecule is necessary for APLP2's effect on MHC class I expression at the plasma membrane, as opposed to a model in which APLP2 exercises its effect by a more indirect means (e.g., via binding to a third protein). New findings from our laboratory indicate that APLP2's effect on MHC class I expression is due to an APLP2-induced increase in MHC class I endocytosis (data not shown). Thus, the role of the APLP2-MHC class I interaction appears to be to control MHC class I cell surface expression via regulation of the process of internalization of MHC class I molecules.
These new data show that APLP2 interacts differentially with several mouse MHC class I allotypes, displaying disparate affinity, intracellular co-localization, and functional impact. We have also demonstrated that APLP2 association with H2 class I molecules is influenced by more than one domain of the MHC class I heavy chain and by the sequence of the β 2 m light chain with which the heavy chain is associated. Our new studies support a role for APLP2 in influencing MHC class I molecules to varied extents, by binding to multiple molecular sites on the MHC heavy chain.
